Instanosis, Inc.
Milford, DE · Medtech · Private
Rapid point-of-care lateral flow assay strip for fentanyl detection in saliva (sFENTANYL)
- Grants
- $7.2M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Ultrasensitive PSA Quantitation Using Smartphone to Reduce Prostate Cancer Monitoring Disparities | $341,668 | |
| Federal grant | Department of Health and Human Services · Phase I · A Lateral Flow Assay for Rapid Saliva Fentanyl Detection (sFENTANYL) | $406,352 | |
| Federal grant | Department of Health and Human Services · Phase I · A Lateral Flow Assay for Rapid Saliva Fentanyl Detection (sFENTANYL) | $149,798 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Instrument-free and High Sensitivity Over-the-counter Urine Fentanyl Testing | $403,636 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Instrument-free and High Sensitivity Over-the-counter Urine Fentanyl Testing | $1,544,462 | |
| Federal grant | Department of Health and Human Services · Phase II · A Rapid, Sensitive and Instrument-free Oral Fluid Fentanyl Test | $1,576,513 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid, Instrument-free and High Sensitivity Over-the-counter Urine Fentanyl Testing | $1,399,878 | |
| Federal grant | Department of Health and Human Services · Phase II · A Rapid, Sensitive and Instrument-free Oral Fluid Fentanyl Test | $1,414,924 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1167 | Logiq.ai Inc. | — | $1.5M |
| 1168 | APTUS BIOSCIENCES LLC | — | — |
| 1169 | Optilume Stricture, LLC | — | $954K |
| 1170 | Instanosis, Inc. | — | — |
| 1171 | OSCILLOSCAPE, LLC | — | $165K |
| 1172 | PULSE BIOSCIENCES, INC. | — | $93M |
| 1173 | Epica International, Inc. | — | $19M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.